These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 31837192)
21. Production of recombinant β-glucocerebrosidase in wild-type and glycoengineered transgenic Nicotiana benthamiana root cultures with different N-glycan profiles. Uthailak N; Kajiura H; Misaki R; Fujiyama K J Biosci Bioeng; 2022 May; 133(5):481-488. PubMed ID: 35190260 [TBL] [Abstract][Full Text] [Related]
22. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues. Raju TS; Briggs JB; Chamow SM; Winkler ME; Jones AJ Biochemistry; 2001 Jul; 40(30):8868-76. PubMed ID: 11467948 [TBL] [Abstract][Full Text] [Related]
23. Impaired galactosylation of core 2 O-glycans in erythrocytes of beta1,4-galactosyltransferase knockout mice. Kotani N; Asano M; Iwakura Y; Takasaki S Biochem Biophys Res Commun; 1999 Jun; 260(1):94-8. PubMed ID: 10381349 [TBL] [Abstract][Full Text] [Related]
24. Glycoform Modification of Secreted Recombinant Glycoproteins through Kifunensine Addition during Transient Vacuum Agroinfiltration. Xiong Y; Li Q; Kailemia MJ; Lebrilla CB; Nandi S; McDonald KA Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562594 [TBL] [Abstract][Full Text] [Related]
25. Deletion of fucose residues in plant N-glycans by repression of the GDP-mannose 4,6-dehydratase gene using virus-induced gene silencing and RNA interference. Matsuo K; Matsumura T Plant Biotechnol J; 2011 Feb; 9(2):264-81. PubMed ID: 20731789 [TBL] [Abstract][Full Text] [Related]
26. Expression of natural human β1,4-GalT1 variants and of non-mammalian homologues in plants leads to differences in galactosylation of N-glycans. Hesselink T; Rouwendal GJ; Henquet MG; Florack DE; Helsper JP; Bosch D Transgenic Res; 2014 Oct; 23(5):717-28. PubMed ID: 25082356 [TBL] [Abstract][Full Text] [Related]
27. Exploring Site-Specific N-Glycosylation of HEK293 and Plant-Produced Human IgA Isotypes. Göritzer K; Maresch D; Altmann F; Obinger C; Strasser R J Proteome Res; 2017 Jul; 16(7):2560-2570. PubMed ID: 28516782 [TBL] [Abstract][Full Text] [Related]
28. β-Hexosaminidases Along the Secretory Pathway of Alvisi N; van Noort K; Dwiani S; Geschiere N; Sukarta O; Varossieau K; Nguyen DL; Strasser R; Hokke CH; Schots A; Wilbers RHP Front Plant Sci; 2021; 12():638454. PubMed ID: 33815445 [TBL] [Abstract][Full Text] [Related]
29. Production of different glycosylation variants of the tumour-targeting mAb H10 in Nicotiana benthamiana: influence on expression yield and antibody degradation. Lombardi R; Donini M; Villani ME; Brunetti P; Fujiyama K; Kajiura H; Paul M; Ma JK; Benvenuto E Transgenic Res; 2012 Oct; 21(5):1005-21. PubMed ID: 22238065 [TBL] [Abstract][Full Text] [Related]
30. Stable expression of human beta1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns. Palacpac NQ; Yoshida S; Sakai H; Kimura Y; Fujiyama K; Yoshida T; Seki T Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4692-7. PubMed ID: 10200324 [TBL] [Abstract][Full Text] [Related]
31. Knockout of mouse beta 1,4-galactosyltransferase-1 gene results in a dramatic shift of outer chain moieties of N-glycans from type 2 to type 1 chains in hepatic membrane and plasma glycoproteins. Kotani N; Asano M; Iwakura Y; Takasaki S Biochem J; 2001 Aug; 357(Pt 3):827-34. PubMed ID: 11463354 [TBL] [Abstract][Full Text] [Related]
32. Production of complex multiantennary N-glycans in Nicotiana benthamiana plants. Nagels B; Van Damme EJ; Pabst M; Callewaert N; Weterings K Plant Physiol; 2011 Mar; 155(3):1103-12. PubMed ID: 21233332 [TBL] [Abstract][Full Text] [Related]
33. Using glyco-engineering to produce therapeutic proteins. Dicker M; Strasser R Expert Opin Biol Ther; 2015; 15(10):1501-16. PubMed ID: 26175280 [TBL] [Abstract][Full Text] [Related]
34. Establishment of a tobacco BY2 cell line devoid of plant-specific xylose and fucose as a platform for the production of biotherapeutic proteins. Hanania U; Ariel T; Tekoah Y; Fux L; Sheva M; Gubbay Y; Weiss M; Oz D; Azulay Y; Turbovski A; Forster Y; Shaaltiel Y Plant Biotechnol J; 2017 Sep; 15(9):1120-1129. PubMed ID: 28160363 [TBL] [Abstract][Full Text] [Related]
35. Engineering nucleotide sugar synthesis pathways for independent and simultaneous modulation of N-glycan galactosylation and fucosylation in CHO cells. Prabhu A; Shanmugam D; Gadgil M Metab Eng; 2022 Nov; 74():61-71. PubMed ID: 36152932 [TBL] [Abstract][Full Text] [Related]
37. Beta galactosidases in Arabidopsis and tomato - a mini review. Chandrasekar B; van der Hoorn RA Biochem Soc Trans; 2016 Feb; 44(1):150-8. PubMed ID: 26862200 [TBL] [Abstract][Full Text] [Related]
38. Generation of biologically active multi-sialylated recombinant human EPOFc in plants. Castilho A; Neumann L; Gattinger P; Strasser R; Vorauer-Uhl K; Sterovsky T; Altmann F; Steinkellner H PLoS One; 2013; 8(1):e54836. PubMed ID: 23372778 [TBL] [Abstract][Full Text] [Related]
39. Transient Glyco-Engineering to Produce Recombinant IgA1 with Defined N- and O-Glycans in Plants. Dicker M; Tschofen M; Maresch D; König J; Juarez P; Orzaez D; Altmann F; Steinkellner H; Strasser R Front Plant Sci; 2016; 7():18. PubMed ID: 26858738 [TBL] [Abstract][Full Text] [Related]